Atenix Medicamenta Ecuatoriana

Adium (formerly Medicamenta Ecuatoriana S.A.) is a leading pharmaceutical company in Ecuador with nearly 40 years of experience in the development, manufacturing, and commercialization of innovative healthcare products. As a key subsidiary of the regional Adium group, the company provides a broad portfolio across 15 therapeutic areas, including oncology, cardiology, and central nervous system disorders. Adium Ecuador serves as a strategic partner for global biotechnology and pharmaceutical firms, facilitating the distribution of advanced therapies such as Moderna's COVID-19 vaccine. The company operates local production facilities and maintains a strong presence in the Ecuadorian healthcare system through its extensive distribution network and medical promotion activities.